Aslan Fred
Reporting owner on Forms 3, 4 and 5, CIK 1909362.
Aslan Fred reported on 1 issuer in 4 filings, the latest a Form 4 filed 2026-11-18.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ARTV · Artiva Biotherapeutics, Inc.CIK 1817241 | director, officer (Chief Executive Officer) | 4 | 2026-11-18 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ARTV · Artiva Biotherapeutics, Inc.Common Stock | 2026-11-17 | S sold | -119,771 | $3.9119 | 1,337,657 | Form 4 |
| ARTV · Artiva Biotherapeutics, Inc.Common Stock | 2026-11-02 | S sold | -62,178 | $4.1811 | 1,457,428 | Form 4 |
| ARTV · Artiva Biotherapeutics, Inc.Common Stock | 2026-10-06 | S sold | -23,463 | $7.1977 | 1,519,606 | Form 4 |
| ARTV · Artiva Biotherapeutics, Inc.Common Stock | 2026-10-05 | S sold | -61,696 | $6.8372 | 1,543,069 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-467071 | Artiva Biotherapeutics, Inc. | 2026-11-18 | ||
| Form 4 0001193125-26-445312 | Artiva Biotherapeutics, Inc. | 2026-11-03 | ||
| Form 4 0001193125-26-416953 | Artiva Biotherapeutics, Inc. | 2026-10-07 | ||
| Form 4 0001193125-26-415527 | Artiva Biotherapeutics, Inc. | 2026-10-06 |